AstraZeneca’s Evusheld Wins EU Marketing Nod For Preventing COVID-19
If Approved Evusheld Will Become The EU’s Eighth COVID-19 Treatment
Executive Summary
The European Commission is expected to make a “rapid decision” on the European Medicines Agency’s recommendation today that Evusheld should be approved.
You may also be interested in...
AstraZeneca's Evusheld Revenue Stream To Dry Up Soon
The revenue boost Evusheld has given AstraZeneca over the past year will grind to a halt now that the FDA, as expected, has pulled approval for the antibody combo on the grounds it is ineffective against most SARS-CoV-2 variants circulating in the US.
AZ’s Evusheld Receives World-First Approval As COVID-19 Treatment, In Japan
Japan has approved Evusheld for both the prevention of infection in people who have not been exposed to the virus and, for the first time globally, as a treatment. The country's government will purchase 300,000 units from AZ amid global supplies that have been limited due to the surging need for the drug.
Janssen’s Multiple Myeloma Gene Therapy On Track For EU-Wide Approval
The European Medicines Agency’s human medicines committee has recommended five new drugs for use in the EU at its latest monthly meeting.